Tumor embolization

Effective guidance in treatment and decision-making for tumor embolization

The ability to detect and differentiate nodules and identify tiny feeder vessels is critical to determining proper therapy. Navigating to the region of interest by reaching all feeders, while remaining selective to the lesion and sparing healthy tissue increases the opportunity for success. Confirmation of treatment endpoint and treatment success while the patient is still on the table boosts clinical outcome confidence and enables efficient follow-up treatment planning.

Overview

Overview

Supporting advanced techniques for tumor embolization, reliably and efficiently

Adoption of chemo/radioembolization techniques for liver lesions, such as transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT or TARE) drives the need for standardization and efficiency. In case after case, you must reliably and consistently locate the tumor(s), identify all feeder vessels and plan and execute the appropriate interventional approach.
Benefits
Benefits
Decide, guide, treat and confirm in tumor embolization

Decide treatment using whole liver coverage with CBCT Open, excellent artery and tumor visualization with CBCT Dual, and image fusion with Dual View. The DualPhase acquisition and Dual View functions allow simultaneous visualization of two sequentially acquired 3D data sets

Facilitate guidance and selective treatment by automatically detecting artery feeders with EmboGuide and overlaying the planned roadmap onto the live X-ray image

Monitor treatment using low-dose fluoroscopy with ClarityIQ

Confirm treatment completion through post-embolization 3D image fusion with Dual View
Key features
Key features
Effective guidance in treatment and decision making

SmartCT Soft Tissue with CBCT Open for whole liver coverage allows off-center positioning and better centering of the Field of View (FOV) to visualize peripheral tumors¹

CBCT Dual enables 3D acquisition of an arterial phase to visualize vascular structures and post-arterial accumulation of contrast medium in a single automatic step

Visualize targeted deposition of embolic material in the tumor with post-embolization 3D imaging²

Simultaneously visualize pre- and post-embolization images with Dual View image fusion to assess treatment endpoint

Demonstrated results of EmboGuide in tumor embolization

Our Automatic Feeder Detection solution can significantly improve feeding artery detection compared to using Cone Beam CT alone. EmboGuide supports you in maximizing the efficacy of your TACE procedures as it potentially enhances your sensitivity, reduces false positives and maximizes inter-reader agreement.³

86% sensitivity³

Automatic Feeder Detection software improved feeding artery detection rates to 86% sensitivity³ during transarterial chemoembolization of HCC lesions with better user reproducibility compared with Cone-Beam CT alone.

57% fewer false positives³

Automatic Feeder Detection software can reduce false positives by 57%.³

99.7% reader agreement³

AFD software significantly improved detection of feeding arteries with 99.7% reader agreement.³

22% less recurrence using CBCT vs 2D imaging alone⁴

A study showed that the recurrence rate of liver cancer within 36 months after TACE treatment is 52% using 2D imaging alone, and 30% using Cone Beam CT monitoring.⁴

Image gallery

Toggle view

Featured products for tumor embolization

Azurion 7 with FlexArm

The ceiling-mounted Philips Azurion with FlexArm and 20” detector provides unlimited imaging flexibility and exceptional positioning freedom. Seamlessly control relevant applications from a single touchscreen at tableside to help make fast, informed decisions while remaining in the sterile field.

View product

SmartCT 3D imaging

Easily control advanced 3D acquisition, visualization and measurements at tableside to improve lab flexibility and efficiency. Semi-automated segmentation tasks speed up 3D image analysis and step-by-step guidance throughout the entire 3D image acquisition remove guesswork for superior patient care.

View product

EmboGuide automatic feeder detection

EmboGuide provides efficient, workflow-based live 3D guidance with automatic feeder detection to navigate to each segmented tumor target for selective or super-selective embolization of hyper vascular tumors.

View product

“SmartCT has brought us at tableside all the capacity to manipulate the images. We could navigate in 3D and the volumes that we have already acquired. We could stretch this vessel, could have the calculation of the diameter and the length.”

Dr. Hicham Kobeiter,

Hospital Henri-Mondor AP-HP,

Creteil, France

Documentation

Resources: Onco suite brochure (1.44MB)

Azurion with FlexArm brochure (700.0KB)

Azurion whitepaper: Reduction of procedure time by 17% (4.03MB)

SmartCT brochure (2.42MB)

Footnotes

[1] Schernthaner RE et al, Feasibility of a Modified Cone-Beam CT Rotation Trajectory to Improve Liver Periphery Visualization during Transarterial Chemoembolization, Radiology. 2015; 277(3):833–4

[2] Levi EB, et al. First human experience with directly image-able iodinated embolization microbeads. Cardiovascular and interventional radiology, vol 39, issue 8, 1177-1186, 2016

[3] Chiaradia et al, J J,Sensitivity and Reproducibility of AFD Software for HCC, Vasc Interv Radiol 2018;29:425-431.

[4] Miyayama et al., Comparison of Local Control in Transcatheter Arterial hemoembolization of Hepatocellular Carcinoma ≤6 Cm With or Without Intraprocedural Monitoring of the Embolized Area Using Cone-Beam Computed Tomography Cardiovasc Intervent Radiol , 2014, 37 (2), 388-95.

Tumor embolization

Effective guidance in treatment and decision-making for tumor embolization

Supporting advanced techniques for tumor embolization, reliably and efficiently

Decide, guide, treat and confirm in tumor embolization

Effective guidance in treatment and decision making

Demonstrated results of EmboGuide in tumor embolization

86% sensitivity3

Automatic Feeder Detection software improved feeding artery detection rates to 86% sensitivity3 during transarterial chemoembolization of HCC lesions with better user reproducibility compared with Cone-Beam CT alone.

57% fewer false positives3

99.7% reader agreement3

22% less recurrence using CBCT vs 2D imaging alone4

Image gallery

Featured products for tumor embolization

Azurion 7 with FlexArm

SmartCT 3D imaging

EmboGuide automatic feeder detection

Documentation

Footnotes

86% sensitivity³

Automatic Feeder Detection software improved feeding artery detection rates to 86% sensitivity³ during transarterial chemoembolization of HCC lesions with better user reproducibility compared with Cone-Beam CT alone.

57% fewer false positives³

99.7% reader agreement³

22% less recurrence using CBCT vs 2D imaging alone⁴